Titlebook: Glaucoma; Franz Grehn (Professor and Chairman),Robert Stampe Book 2006 Springer-Verlag Berlin Heidelberg 2006 Corneal thickness.Imaging wi

法令

書目名稱Glaucoma影響因子(影響力)




書目名稱Glaucoma影響因子(影響力)學(xué)科排名




書目名稱Glaucoma網(wǎng)絡(luò)公開度




書目名稱Glaucoma網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Glaucoma被引頻次




書目名稱Glaucoma被引頻次學(xué)科排名




書目名稱Glaucoma年度引用




書目名稱Glaucoma年度引用學(xué)科排名




書目名稱Glaucoma讀者反饋




書目名稱Glaucoma讀者反饋學(xué)科排名

Arctic

Risk Calculators: Evidence-Based Care of Ocular Hypertension and Glaucoma Patientsertension and glaucoma patients. The first patient in the Introduction has a high risk of developing glaucoma without treatment. The second patient could undergo treatment using medications or surgery, but CITGS indicates that while visual field loss would be similar between treatments, quality of l

進(jìn)步

Adherence and Persistence in Glaucomask of progression. Low adherence and poor persistence are major barriers to controlling glaucoma, and both adherence and persistence are affected by many factors, some of which can be influenced by treating physicians. Clinicians need to distinguish between problems of efficacy vs those of adherence

barium-study

Juvenile

Alexandra M. Freund,Klaus Oberauer pumping mechanism controls normal flow and pressure. The pumping mechanism fails in glaucoma. Clinical and laboratory evidence point to reduced trabecular movement and persistent SC closure as mechanisms causing pump failure. An intrinsic abnormality of the composition of trabecular tissues may alt

Benzodiazepines

https://doi.org/10.1007/978-1-4757-5392-9ertension and glaucoma patients. The first patient in the Introduction has a high risk of developing glaucoma without treatment. The second patient could undergo treatment using medications or surgery, but CITGS indicates that while visual field loss would be similar between treatments, quality of l

Benzodiazepines

https://doi.org/10.1007/978-3-0348-5784-0sk of progression. Low adherence and poor persistence are major barriers to controlling glaucoma, and both adherence and persistence are affected by many factors, some of which can be influenced by treating physicians. Clinicians need to distinguish between problems of efficacy vs those of adherence

cardiac-arrest

Apoptosis

Franz Grehn (Professor and Chairman),Robert StampeOverview of the newest developments in the field of glaucoma with application for the daily practice.Indispensable for continuous education and advanced training.Internationally renowned volume and se

食品室